8.55 +0.00 (0.00%)
NBIX
| Trade NBIX now with |
Stock Details
Last Trade:8.55 Change:+0.00 (0.00%) Prev Close:8.55 Open: 987.40 Days Range:8.55 – 8.55 52 Week Range: 5.42 - 9.98 Volume:2500 P/E: 12.21EPS:0.70
Recent Blog Posts
Blog Posts on 01/27/12 at 10:07am
Executing And Creating Value, Neurocrine Biosciences Is Worth Watching
Executing And Creating Value, Neurocrine Biosciences Is Worth Watching
Blog Posts on 12/14/11 at 11:14am
Top Q3 Picks Of Small-Cap Biotech Focused Hedge Fund Perceptive Advisors
Top Q3 Picks Of Small-Cap Biotech Focused Hedge Fund Perceptive Advisors
Blog Posts on 11/09/11 at 5:58pm
Neurocrine Biosciences Presentation at 2011 Credit Suisse Annual Health Care Conference - Conference Call Transcript
Neurocrine Biosciences Presentation at 2011 Credit Suisse Annual Health Care Conference - Conference Call Transcript
Blog Posts on 11/04/11 at 8:47am
10 Small-Cap Stocks With Strong Profitability And Plenty Of Cash On Hand
10 Small-Cap Stocks With Strong Profitability And Plenty Of Cash On Hand
Blog Posts on 10/31/11 at 11:08pm
Neurocrine Biosciences' CEO Discusses Q3 2011 Results - Earnings Call Transcript
Neurocrine Biosciences' CEO Discusses Q3 2011 Results - Earnings Call Transcript
Blog Posts on 10/17/11 at 7:57am
Insider Buying And A Pending Catalyst Send Neurocrine Bioscience's Shares Higher
Insider Buying And A Pending Catalyst Send Neurocrine Bioscience's Shares Higher
Blog Posts on 08/18/11 at 8:47am
The Short Case for Mesoblast: Little Upside Left, No Need for a Catalyst
The Short Case for Mesoblast: Little Upside Left, No Need for a Catalyst
Blog Posts on 07/29/11 at 1:12pm
Neurocrine Biosciences' CEO Discusses Q2 2011 Results - Earnings Call Transcript
Neurocrine Biosciences' CEO Discusses Q2 2011 Results - Earnings Call Transcript
Blog Posts on 05/04/11 at 2:08pm
Neurocrine Biosciences, Inc. CEO Discusses Q1 2011 Results - Earnings Call Transcript
Neurocrine Biosciences, Inc. CEO Discusses Q1 2011 Results - Earnings Call Transcript


